The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 19, 2019

Filed:

Jun. 20, 2014
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Heng Zhu, Towson, MD (US);

Prashant Desai, Owings Mills, MD (US);

Min Li, Lutherville-Timonium, MD (US);

Shaohui Hu, Baltimore, MD (US);

Assignee:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); G01N 33/543 (2006.01); G01N 33/566 (2006.01); G01N 33/58 (2006.01); C07K 1/04 (2006.01); G01N 33/68 (2006.01); A61B 17/34 (2006.01); A61B 18/02 (2006.01); G01N 33/74 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61B 17/3478 (2013.01); A61B 18/02 (2013.01); A61B 18/0218 (2013.01); C07K 1/047 (2013.01); G01N 33/566 (2013.01); G01N 33/6854 (2013.01); G01N 33/74 (2013.01); A61B 2018/0038 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0275 (2013.01); A61B 2217/005 (2013.01); C07K 2319/03 (2013.01); C07K 2319/735 (2013.01); C12N 2710/16621 (2013.01); C12N 2710/16645 (2013.01); C12N 2810/855 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/726 (2013.01);
Abstract

Provided herein are recombinant virion arrays comprising human membrane bound proteins that retain their native conformations and/or interactions, recombinant HSV-1 virions, and methods of use including high-content, high-throughput assays for screening for ligands and/or drugs that bind human membrane bound proteins, diagnostic assays, proteomic assays, and biosensor assays. Also provided are recombinant HSV-1 virions comprising an envelope comprising a plurality of heterologous membrane bound proteins that retain their native conformations and/or interactions as well as recombinant HSV-1 bacterial artificial chromosome (BAC) clones encoding heterologous membrane polypeptides.


Find Patent Forward Citations

Loading…